Abundant Venture Partners

We are dedicated team of experienced investors who help to enable groundbreaking work by investing in and fostering companies and technologies that advance the future of health. Entrepreneur-friendly strategic investor that speeds access to new healthcare products and services to improve patient care Established by UNC REX Healthcare in 2012 as part of its commitment to innovation Partners with emerging companies throughout North Carolina and the U.S. Leverages the talent and subject matter experts across the UNC REX and UNC Health Care network

Our decades of experience in the healthcare industry has helped us understand what it takes for a new business to make their groundbreaking innovations accessible to everyone. We leverage this understanding of the healthcare landscape to add strategic value to young ventures and help them thrive. All the expertise you need, under one roof Being the drivers behind the success of Zandu Pharma and ZCL Chemicals, we have deep-sector expertise in the healthcare, pharmaceuticals, entrepreneurship and investment dimensions. With our proficiency, we aim to make top-quality healthcare accessible to anyone who requires it. Product of Health 4.0 Health 4.0 - a concept derived from the fourth manufacturing revolution (Industry 4.0), refers to the modernisation of healthcare to make it smarter and more connected using the internet of things and cloud computing. Ultimately, it aims to use large amounts of data to make healthcare more accessible to people without the element of physical human interaction. Standing tall with you, every step of the way Our experienced team of professionals are proactive in their approach and truly believe in our philosophy. Together, we make sure your business gets the support it needs to scale up. Piloting innovations for the people, by the people Our expertise and experience in this space add merit to businesses. Founded by a healthcare entrepreneur. We understand the space and have built large healthcare businesses. We bring more than just the investment to the table by adding strategic value to the business. Our philosophy is - To invest only in companies where we can add strategic value, creating a win-win situation for the company, the founder, and the investors.

FCA invests in digital health and technology-enabled healthcare services companies across the seed to late-stage Series A stages. Criteria FCA Venture Partners' flagship fund invests $3-6m as the lead investor in Series A rounds or as a participant in Series B rounds, and our seed fund, FCA Health Innovations, invests $1-3m as a lead investor in seed rounds or as a participant in Series A rounds.

We have a long-term interest in innovation, disruptive technology, and the entrepreneurs that lead their companies from early stage to sustainable growth. We have been operators in building technology products, teams, and companies since the early days of the internet and in the technology sector for over twenty-five (25) years, and pursuing innovative and scalable technology companies for strategic investments; opportunities that converge leading-edge technology and meaningful purpose together to create enduring products and services that make our lives better and our world safer for generations. The meaning behind "inhite" - \ in·hite \ - ˈ [ in ]·[ h AY t ] ˈ - we are into high tech ventures, and we make investments in healthcare innovation and technology endeavors, targeting Healthcare Artificial Intelligence (AI) growth startup companies. @inhite, we are focused on supporting creative founders, entrepreneurs, that are inspired by innovation and technology and can innovate technology products that can provide efficient and effective services to market while generating sustainable and ongoing growth for years to come. Having been there and done that ourselves, we add operating experience and strategic capital to portfolio companies. We seek to support founders who are building scalable companies that possess recurring revenues, strong technical barriers, and competitive advantages in the market in which the teams possess the driving force and in sync with us through the process.

We take a responsive, service-oriented approach with our portfolio companies, leveraging a proprietary technology platform designed to systematize and scale the power of our network. Our funds typically invest $1M - $2M in early stage companies and $3M - $5M in growth stage companies. NextGen invests in early-stage founders building category-defining B2B software companies in healthcare, data infrastructure, and financial technology. We recently closed our third fund that will focus on pre-seed and seed investments in these categories. Our portfolio consists of 70 companies including Everly Health, Mercury, Maven Clinic, Syncari, Hone, Carta, TripleBlind, Pluto Health, and Dusty Robotics among others.'

From startups to more experienced companies, we offer investment capital joined with the expertise of an integrated health system and health plan. We actively partner with organizations to support their success and positively impact the communities we serve. We also actively partner with other like-minded health care organizations and strategic investors to collectively share expertise and drive scale. By leveraging our venture network, we will drive growth and value for portfolio companies while changing the future of health care. What we invest in:Companies and solutions aligned with our vision and strategic priorities Experienced, in-place management teams Well-developed, unique value propositions and business models Existing customers and revenue stream of $1M or more Solutions that amplify our clinical and operational expertise What we do not invest in:Class III medical devices Pharmaceuticals or biotech Pre-revenue companies* Solutions outside our mission, vision and values Other ways we work with emerging innovation companies to create value:Pool resources De-risk commercialization Collaboration agreements